IGFBP3 and neoplasm: IGFBP3/5/6/7 expression was significantly elevated in pathological stages II–IV compared with pathological stage I. IGFBP3/5/7 expression was also significantly increased in advanced T-stage patients and was associated with tumor progression in STAD.